199 related articles for article (PubMed ID: 12849298)
21. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease.
Thompson AG; Thomas R
Immunol Cell Biol; 2002 Dec; 80(6):509-19. PubMed ID: 12406384
[TBL] [Abstract][Full Text] [Related]
22. Antigen-specific therapy for autoimmune disease.
Harrison LC; Hafler DA
Curr Opin Immunol; 2000 Dec; 12(6):704-11. PubMed ID: 11102776
[TBL] [Abstract][Full Text] [Related]
23. Selective targets for immunotherapy in autoimmune disease.
Yang XD; Tisch R; McDevitt HO
Chem Immunol; 1995; 60():20-31. PubMed ID: 7857527
[No Abstract] [Full Text] [Related]
24. Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?
Coleman MA; Steptoe RJ
Autoimmun Rev; 2012 Dec; 12(2):195-203. PubMed ID: 23047179
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy for autoimmune and inflammatory renal diseases.
Jayne DR
Curr Opin Nephrol Hypertens; 1998 May; 7(3):311-5. PubMed ID: 9617563
[TBL] [Abstract][Full Text] [Related]
26. A review: the use of rituximab in neuromuscular diseases.
Ibrahim H; Dimachkie MM; Shaibani A
J Clin Neuromuscul Dis; 2010 Dec; 12(2):91-102. PubMed ID: 21386778
[TBL] [Abstract][Full Text] [Related]
27. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease.
Huber A; Diedrichs-Möhring M; Wildner G
Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538
[TBL] [Abstract][Full Text] [Related]
28. Engineering Immune Tolerance with Biomaterials.
Gammon JM; Jewell CM
Adv Healthc Mater; 2019 Feb; 8(4):e1801419. PubMed ID: 30605264
[TBL] [Abstract][Full Text] [Related]
29. Oral tolerance for treating uveitis - new hope for an old immunological mechanism.
Thurau SR; Wildner G
Prog Retin Eye Res; 2002 Nov; 21(6):577-89. PubMed ID: 12433378
[TBL] [Abstract][Full Text] [Related]
30. Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.
Caspi RR
Immunol Res; 2003; 27(2-3):149-60. PubMed ID: 12857964
[TBL] [Abstract][Full Text] [Related]
31. T-cell-based immunotherapy of autoimmune diseases.
Ulivieri C; Baldari CT
Expert Rev Vaccines; 2013 Mar; 12(3):297-310. PubMed ID: 23496669
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.
Bach JF
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S3-15. PubMed ID: 12110118
[TBL] [Abstract][Full Text] [Related]
33. Advancing research in autoimmune neuromuscular disorders.
Sanders DB
Lancet Neurol; 2022 Feb; 21(2):108-110. PubMed ID: 35065029
[No Abstract] [Full Text] [Related]
34. Complications of intravenous gammaglobulin in neuromuscular and other diseases.
Bertorini TE; Nance AM; Horner LH; Greene W; Gelfand MS; Jaster JH
Muscle Nerve; 1996 Mar; 19(3):388-91. PubMed ID: 8606709
[No Abstract] [Full Text] [Related]
35. Therapy update in nerve, neuromuscular junction and myopathic disorders.
Sadeghian H; Wolfe GI
Curr Opin Neurol; 2010 Oct; 23(5):496-501. PubMed ID: 20664347
[TBL] [Abstract][Full Text] [Related]
36. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease.
Röcken M; Racke M; Shevach EM
Immunol Today; 1996 May; 17(5):225-31. PubMed ID: 8991384
[TBL] [Abstract][Full Text] [Related]
37. Stabilizing human regulatory T cells for tolerance inducing immunotherapy.
He X; Koenen HJ; Slaats JH; Joosten I
Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099
[TBL] [Abstract][Full Text] [Related]
38. Development of novel therapies for MG: Studies in animal models.
Souroujon MC; Brenner T; Fuchs S
Autoimmunity; 2010 Aug; 43(5-6):446-60. PubMed ID: 20298126
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological basis of immunotherapy in autoimmune diseases.
Rouveix B; Blin O
Clin Neuropharmacol; 1993 Apr; 16(2):104-12. PubMed ID: 8477406
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells in tolerance induction for the treatment of autoimmune diseases.
Rescigno M
Eur J Immunol; 2010 Aug; 40(8):2119-23. PubMed ID: 20853497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
